Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
38
days
Trajectory clustering of longitudinal donor chimerism after pediatric hematopoietic stem cell transplantation for non-malignant disorders
Authors
Neta Nevo; Hila Rosenfeld Keidar; Ronit ElhasidShow moreShow less
Affiliations
Department of Pediatric Hemato-Oncology and Bone Marrow Transplantation, Tel Aviv Sourasky University Medical Center, Tel Aviv, Israel; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, IsraelShow moreShow less
105
days
Three-dimensional mesenchymal stromal cell spheroids potently suppress neutrophil extracellular trap formation
Authors
Juliana Borges Vieira; Mariana Alves Antunes Almeida; Carla Medeiros da Silva; Marianna Ribeiro Cabral; Renata Trabach Santos; Christina Maeda Takiya; Elvira Maria Saraiva; Elisa de Assis Faria; Emilly Caroline dos Santos Moraes; Monique Ramos-de-Oliveira; Patricia Rieken Macedo Rocco; Pedro Leme Silva; Fernanda Ferreira CruzShow moreShow less
Affiliations
Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Immunopathology Laboratory, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Laboratory of Innate Immunity, Department of Immunology, Paulo de Goes Institute of Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Center for Technological Development in Health, Oswaldo Cruz Foundation, Rio de Janeiro, BrazilShow moreShow less
170
days
Early detection of chimeric antigen receptor-T-associated neurotoxicity via cytokine monitoring in serum
Authors
Amit Parizat; Onit Alalouf; Danielle Sapir; Nivin Shibli; Ruth Perets; Dvir Aran; Ofrat Beyar Katz; Yoav ShechtmanShow moreShow less
Affiliations
Faculty of Biomedical Engineering, Technion—Israel Institute of Technology, Haifa, Israel; Faculty of Electrical and Computer Engineering, Technion—Israel Institute of Technology, Haifa, Israel; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; Division of Oncology, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel; Clinical Research Institute at Rambam, Rambam Medical Center, Haifa, Israel; Faculty of Biology, Technion—Israel Institute of Technology, Haifa, IsraelShow moreShow less
32
days
Enhanced antitumor efficacy through combined chimeric antigen receptor T cell therapy and CD40 stimulation in syngeneic solid tumor models
Authors
Giulia Golinelli; Ting-Jia Fan; Khatuna Gabunia; Wesley V. Wilson; Charles-Antoine Assenmacher; He N. Xu; Diego Gonzalves; Sofia Castelli; Jordan Reff; David Mai; Omar Johnson; Zachary Ferraro; Aasha Gupta; Mansi Deshmukh; Deeksha Muthumani; Decheng Song; Daniel Martinez; Enrico Radaelli; Jillian Verrelle; Federica Masciotta; Valentino Santori; Shimin Liu; Julia Tchou; Massimo Dominici; Regina M. Young; Andrew J. Rech; Carl H. June; John Scholler; Bruce L. LevineShow moreShow less
Affiliations
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Laboratory of Cellular Therapy, Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy; Comparative Pathology Core, Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Anatomic Pathology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Unit of Methodological and Statistical Support to Clinical Research, Azienda Ospedaliero-Universitaria di Modena Policlinico di Modena, Modena, Italy; Department of Statistics, Informatics, Applications ‘Giuseppe Parenti’ (DISIA), University of Florence, Florence, Italy; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Parker Institute for Cancer Immunotherapy at University of Pennsylvania, University of Pennsylvania, Philadelphia, Pennsylvania, USAShow moreShow less
157
days
Cell therapies: are we doing enough to protect patients and address the barriers to patient access?
Authors
Michael Creane; Bambi J. Grilley; Miguel Forte; Fermin Sanchez-Guijo; Christian Jorgensen; Ivan Martin; Laertis Ikonomou; Sowmya ViswanathanShow moreShow less
Affiliations
HAON Life Science, NovaUCD, Belfield Innovation Park, University College Dublin, Dublin, Ireland; Department of Pediatrics, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA; Kiji Therapeutics, Brussels, Belgium; University of Salamanca, IBSAL-University Hospital of Salamanca, Salamanca, Spain; Institute for Regenerative Medicine and Biotherapy (IRMB), University Hospital of Montpellier, INSERM, Montpellier, France; Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Hôpital Lapeyronie, Montpellier, France; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland; Department of Oral Biology, University at Buffalo, The State University of New York, Buffalo, New York, USA; Cell, Gene and Tissue Engineering Center, University at Buffalo, The State University of New York, Buffalo, New York, USA; Osteoarthritis Research Program, Division of Orthopaedic Surgery, Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada; Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, Division of Hematology, University of Toronto, Toronto, Ontario, CanadaShow moreShow less
83
days
Safety and tolerability of topical mesenchymal stromal cell secretome in persistent corneal epithelial disease—a phase 1b clinical trial
Authors
Farshad Abedi; Jeonghyun (Esther) Kwon; Iskra Araujo; Zarife J. Yucel; Rebecca Jung; Mohammad Soleimani; Seungwon An; Mahmood Ghassemi; Khandeker N Anwar; Zohreh Arabpour; Monazzah A. Sarwar; Elmer Y. Tu; Peiman Hematti; Charlotte E. Joslin; Nadim Mahmud; Ali R. DjalilianShow moreShow less
Affiliations
Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois, Chicago, Illinois, USA; Division of Hematology/Oncology, Department of Medicine, University of Illinois College of Medicine, Chicago, Illinois, USA; Department of Pharmacy Practice, Retzky College of Pharmacy, University of Illinois, Chicago, Illinois, USA; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA; Division of Epidemiology and Biostatistics, University of Illinois at ChicagoShow moreShow less
FAQ
How long does CYTOTHERAPY take to review a manuscript?
As of 2026-11-14, CrushSCI has 15 complete review records for CYTOTHERAPY. The fastest paper went from submission to acceptance in 32 days (Enhanced antitumor efficacy through combined chimeric antigen receptor T cell therapy and CD40 stimulation in syngeneic solid tumor models, received 2026-07-02, accepted 2026-08-03); the slowest took 170 days. The average is 98.9 days and the median is 103 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
